ACM
NRIX icon

Aquatic Capital Management’s Nurix Therapeutics NRIX Stock Holding History

Aquatic Capital Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,820
Closed -$698K – 1681
2025
Q4 		$698K Buy
+36,820
New +$529K 0.02% 643
2025
Q1 		– Sell
-4,610
Closed -$86.9K – 1521
2024
Q4 		$86.9K Buy
+4,610
New +$106K ﹤0.01% 1090
2023
Q4 		– Sell
-1,800
Closed -$14K – 1536
2023
Q3 		$14K Buy
+1,800
New +$16.4K ﹤0.01% 1104
2023
Q2 		– Sell
-1,100
Closed -$10K – 1623
2023
Q1 		$10K Buy
+1,100
New +$11.5K ﹤0.01% 1122

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Aquatic Capital Management's NRIX Position: Q1 2026 in Review

Aquatic Capital Management sold out of Nurix Therapeutics (NRIX) in Q1 2026, closing a stake of 36,820 shares — an estimated $698K sold.

Aquatic Capital Management first reported a position in NRIX in Q1 2023 and held it in 4 quarters. The position peaked at $698K in Q4 2025. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • Aquatic Capital Management reported no remaining Nurix Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 36,820 Nurix Therapeutics shares in Q1 2026, an estimated $698K.
  • Aquatic Capital Management first reported a position in Nurix Therapeutics in Q1 2023 and held it in 4 quarters.
  • Aquatic Capital Management's Nurix Therapeutics position peaked at $698K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.